These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25505949)

  • 1. Pollen-induced antigen presentation by mesenchymal stem cells and T cells from allergic rhinitis.
    Desai MB; Gavrilova T; Liu J; Patel SA; Kartan S; Greco SJ; Capitle E; Rameshwar P
    Clin Transl Immunology; 2013 Oct; 2(10):e7. PubMed ID: 25505949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance-like mediated suppression by mesenchymal stem cells in patients with dust mite allergy-induced asthma.
    Kapoor S; Patel SA; Kartan S; Axelrod D; Capitle E; Rameshwar P
    J Allergy Clin Immunol; 2012 Apr; 129(4):1094-101. PubMed ID: 22196773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cell-derived mesenchymal stem cells activate quiescent T cells and elevate regulatory T cell response via NF-κB in allergic rhinitis patients.
    Fan XL; Zeng QX; Li X; Li CL; Xu ZB; Deng XQ; Shi J; Chen D; Zheng SG; Fu QL
    Stem Cell Res Ther; 2018 Jun; 9(1):170. PubMed ID: 29921316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal T-cell phenotypes in persistent atopic and nonatopic rhinitis show an association with mast cells.
    Powe DG; Huskisson RS; Carney AS; Jenkins D; McEuen AR; Walls AF; Jones NS
    Allergy; 2004 Feb; 59(2):204-12. PubMed ID: 14763935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic administration of bone marrow-derived mesenchymal stromal cells reduces airway inflammation without up-regulating Tregs in experimental asthma.
    Kitoko JZ; de Castro LL; Nascimento AP; Abreu SC; Cruz FF; Arantes AC; Xisto DG; Martins MA; Morales MM; Rocco PRM; Olsen PC
    Clin Exp Allergy; 2018 Feb; 48(2):205-216. PubMed ID: 29068567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effect of tonsil-derived mesenchymal stem cells in a mouse model of allergic rhinitis.
    Samivel R; Kim EH; Chung YJ; Mo JH
    Am J Rhinol Allergy; 2015; 29(4):262-7. PubMed ID: 26085003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of human mesenchymal stem cells on airway inflammation in allergic asthma mice and the underlying mechanism].
    Ren NN; Chen HJ; Chen QL; Eileen J; An YG; Lin Y
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2697-2702. PubMed ID: 28910960
    [No Abstract]   [Full Text] [Related]  

  • 8. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders.
    Del Prete GF; De Carli M; D'Elios MM; Maestrelli P; Ricci M; Fabbri L; Romagnani S
    Eur J Immunol; 1993 Jul; 23(7):1445-9. PubMed ID: 8100770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presenting cells in the nasal mucosa of patients with allergic rhinitis during allergen provocation.
    Godthelp T; Fokkens WJ; Kleinjan A; Holm AF; Mulder PG; Prens EP; Rijntes E
    Clin Exp Allergy; 1996 Jun; 26(6):677-88. PubMed ID: 8809425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does allergen immunotherapy alter the natural course of allergic disorders?
    Yang X
    Drugs; 2001; 61(3):365-74. PubMed ID: 11293647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal mucosa derived-mesenchymal stem cells from mice reduce inflammation via modulating immune responses.
    Yang C; Li J; Lin H; Zhao K; Zheng C
    PLoS One; 2015; 10(3):e0118849. PubMed ID: 25739057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitization to common allergens and its association with allergic disorders at age 4 years: a whole population birth cohort study.
    Arshad SH; Tariq SM; Matthews S; Hakim E
    Pediatrics; 2001 Aug; 108(2):E33. PubMed ID: 11483843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of HLA-DR and CD86 in nasal epithelial cells in allergic rhinitics: antigen presentation to T cells and up-regulation by diesel exhaust particles.
    Takizawa R; Pawankar R; Yamagishi S; Takenaka H; Yagi T
    Clin Exp Allergy; 2007 Mar; 37(3):420-33. PubMed ID: 17359392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: relationship to expression of allergic disease.
    Till S; Dickason R; Huston D; Humbert M; Robinson D; Larché M; Durham S; Kay AB; Corrigan C
    J Allergy Clin Immunol; 1997 Apr; 99(4):563-9. PubMed ID: 9111503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA.
    Tang KC; Trzaska KA; Smirnov SV; Kotenko SV; Schwander SK; Ellner JJ; Rameshwar P
    J Immunol; 2008 Feb; 180(3):1826-33. PubMed ID: 18209080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we predict allergen-induced asthma in patients with allergic rhinitis?
    Buslau A; Voss S; Herrmann E; Schubert R; Zielen S; Schulze J
    Clin Exp Allergy; 2014 Dec; 44(12):1494-502. PubMed ID: 25270425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen-stimulated interleukin-4 and interferon-gamma production in primary culture: responses of subjects with allergic rhinitis and normal controls.
    Imada M; Simons FE; Jay FT; Hayglass KT
    Immunology; 1995 Jul; 85(3):373-80. PubMed ID: 7558124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individuals.
    Shamji MH; Bellido V; Scadding GW; Layhadi JA; Cheung DK; Calderon MA; Asare A; Gao Z; Turka LA; Tchao N; Togias A; Phippard D; Durham SR
    Allergy; 2015 Feb; 70(2):171-9. PubMed ID: 25377909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season.
    Grindebacke H; Wing K; Andersson AC; Suri-Payer E; Rak S; Rudin A
    Clin Exp Allergy; 2004 Sep; 34(9):1364-72. PubMed ID: 15347368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart.
    Huang XP; Ludke A; Dhingra S; Guo J; Sun Z; Zhang L; Weisel RD; Li RK
    FASEB J; 2016 Sep; 30(9):3069-82. PubMed ID: 27221978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.